General AML,   FLT3

Dr. Jordi Esteve | EBMT 2018 | Key measures for prevention of post-transplant relapse in AML

L: English
Watch Spanish version

At the  44th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting, 18–21 Mar 2018, Dr. Jordi Esteve (chair of our European Steering Committee) from Hospital Clinic of Barcelona, Barcelona, ES, discusses key measures for the prevention of post-transplant relapse in acute myeloid leukemia (AML) including the use of pharmacological measures such as FLT3 inhibitors and immunological measures such as preemptive or prophylactic DLI. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF